Gender disparities in the assessment and management of cardiovascular risk in primary care: The AusHEART study

European Journal of Cardiovascular Prevention and Rehabilitation

Volumn 18, Issue 3, 2011, Pages 498-503

  Turnbull, Fiona ^a   Arima, Hisatomi ^a   Heeley, Emma ^a   Cass, Alan ^a   Chalmers, John ^a   Morgan, Claire ^b   Patel, Anushka ^a   Peiris, David ^a   Weekes, Andrew ^b   Anderson, Craig ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Servier Laboratories (Australia) Pty Ltd   (Australia)

Author keywords

Absolute risk; Cardiovascular risk; Gender; Primary care

Indexed keywords

ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FEMALE; GENERAL PRACTITIONER; GROUPS BY AGE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SEX DIFFERENCE;

AGED; AUSTRALIA; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; HEALTHCARE DISPARITIES; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS;

EID: 79959202888     PISSN: 17418267     EISSN: 17418275     Source Type: Journal    
DOI: 10.1177/1741826710389369     Document Type: Article

References (16)

1. Australian Institute of Health and Welfare (AIHW). Impact of falling cardiovascular disease death rates: deaths delayed and years of life extended. Bulletin no. 70. Cat. no. AUS 113 ed. Canberra: AIHW, 2009.
2. Bello N and Mosca L. Epidemiology of coronary heart disease in women. Prog Cardiovasc Dis 2004; 46: 287-295. (Pubitemid 38201291)
3. World Health Organization. World health statistics. Geneva: WHO, 2009.
4. Mosca L, Linfante A, Benjamin E, Berra K, Hayes S, Walsh B, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 2005; 111: 499-510. (Pubitemid 40204436)
5. Blomkalns A, Chen A, Hochman J, Peterson E, Trynosky K, Diercks D, et al. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: Large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol 2005; 45: 832-837. (Pubitemid 40347306)
6. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001; 22: 554-572.
7. Heeley E, Peiris D, Patel A, Cass A, Weekes A, Morgan C, et al. Cardiovascular risk perception and evidence-practice gaps in Australian general practice (the AusHEART study). Med J Aust 2010; 192: 254-259.
8. Anderson KM, Odell PM, Wilson PWF and Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991; 121: 293-298.
9. Barros AJ and Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Meth 2003; 3: 21.
10. Torley D, Zwar N, Comino E and Harris M. GPs' views of absolute cardiovascular risk and its role in primary prevention. Aust Fam Physician 2005; 34: 503-505.
11. Bartys S, Baker D, Lewis P and Middleton E. Inequity in recording of risk in a local population-based screening programme for cardiovascular disease. Eur J Cardiovasc Prev Rehabil 2005; 12: 63-67. (Pubitemid 40388295)
12. Furze G and Lewin B. Causal attributions for angina: results of an interview study. Coron Health Care 2000; 4: 130-134.
13. Hart P. Women's perceptions of coronary heart disease: an integrative review. J Cardiovasc Nurs 2005; 20: 170-176.
14. Mosca L, Merz N, Blumenthal R, Cziraky M, Fabunmi R, Sarawate C, et al. Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting. Circulation 2005; 111: 488-493. (Pubitemid 40204434)
15. Miller M, Byington R, Hunninghake D, Pitt B and Furberg C for the Prospective Randomised Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) Investigators. Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centres in the United States and Canada. Arch Intern Med 2000; 160: 343-347.
16. Ridker P, Cook N, Lee I, Gordon D, Gaziano J, Manson J, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005; 352: 1293-1304.